Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Servier
Centre Leon Berard
Ricoh USA, Inc.
Quironsalud
Istituto Ortopedico Rizzoli
Var2 Pharmaceuticals
Abramson Cancer Center at Penn Medicine
University of Iowa
Memorial Sloan Kettering Cancer Center
UNICANCER
Medical College of Wisconsin